
zzso is an important zzso zzso Despite the use of several combination chemotherapy regimens that include zzso the best dose and schedule for zzso remains zzso The schedule dependency for small cell lung cancer is now known, and it is likely the same for other sensitive zzso zzso lymphoma, germ cell zzso Recent data suggest that even a more extended schedule of administration zzso 14 to 21 zzso may be more effective than the standard 3- to zzso zzso Several studies have assessed plasma levels in reference to dose, schedule, and tumor zzso zzso data suggest that high peak levels zzso zzso 5 to 10 zzso are associated with more severe zzso than lower peak plasma levels zzso 1 to 3 zzso Response rates and survival in small cell lung cancer patients given low daily doses for 14 to 21 days are comparable with results achieved with standard doses given for 3 to 5 zzso zzso data from several studies suggest that administering low doses for a prolonged schedule is a superior method of zzso zzso Other studies including zzso comparisons are necessary to confirm these zzso 

